Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Chlamydia testing
1.2.3 Syphilis testing
1.2.4 Gonorrhoea testing
1.2.5 Herpes simplex virus testing
1.2.6 Human papilloma virus testing
1.2.7 Human immunodeficiency virus testing
1.3 Market by Application
1.3.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Government organizations
1.3.3 Hospitals
1.3.4 Diagnostic clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Perspective (2018-2033)
2.2 Sexually Transmitted Disease (STD) Diagnosis Growth Trends by Region
2.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Region (2018-2023)
2.2.3 Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Region (2024-2033)
2.3 Sexually Transmitted Disease (STD) Diagnosis Market Dynamics
2.3.1 Sexually Transmitted Disease (STD) Diagnosis Industry Trends
2.3.2 Sexually Transmitted Disease (STD) Diagnosis Market Drivers
2.3.3 Sexually Transmitted Disease (STD) Diagnosis Market Challenges
2.3.4 Sexually Transmitted Disease (STD) Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue
3.1.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue (2018-2023)
3.1.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Players (2018-2023)
3.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sexually Transmitted Disease (STD) Diagnosis Revenue
3.4 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio
3.4.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2022
3.5 Sexually Transmitted Disease (STD) Diagnosis Key Players Head office and Area Served
3.6 Key Players Sexually Transmitted Disease (STD) Diagnosis Product Solution and Service
3.7 Date of Enter into Sexually Transmitted Disease (STD) Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Type
4.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Type (2018-2023)
4.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2024-2033)
5 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Application
5.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Application (2018-2023)
5.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size (2018-2033)
6.2 North America Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2023)
6.4 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size (2018-2033)
7.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2023)
7.4 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size (2018-2033)
8.2 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2018-2023)
8.4 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size (2018-2033)
9.2 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2023)
9.4 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size (2018-2033)
10.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2023)
10.4 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Introduction
11.1.4 Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Introduction
11.2.4 Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Introduction
11.3.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Aposcience
11.4.1 Aposcience Company Detail
11.4.2 Aposcience Business Overview
11.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Introduction
11.4.4 Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.4.5 Aposcience Recent Development
11.5 BCR Diagnostics
11.5.1 BCR Diagnostics Company Detail
11.5.2 BCR Diagnostics Business Overview
11.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
11.5.4 BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.5.5 BCR Diagnostics Recent Development
11.6 BD Medical
11.6.1 BD Medical Company Detail
11.6.2 BD Medical Business Overview
11.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Introduction
11.6.4 BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.6.5 BD Medical Recent Development
11.7 Biocartis
11.7.1 Biocartis Company Detail
11.7.2 Biocartis Business Overview
11.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Introduction
11.7.4 Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.7.5 Biocartis Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Detail
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Introduction
11.8.4 BioMerieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.8.5 BioMerieux Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Detail
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Introduction
11.9.4 Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.9.5 Bio-Rad Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Detail
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Introduction
11.10.4 Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.10.5 Cepheid Recent Development
11.11 Danaher
11.11.1 Danaher Company Detail
11.11.2 Danaher Business Overview
11.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Introduction
11.11.4 Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.11.5 Danaher Recent Development
11.12 DiaSorin
11.12.1 DiaSorin Company Detail
11.12.2 DiaSorin Business Overview
11.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Introduction
11.12.4 DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.12.5 DiaSorin Recent Development
11.13 Quidel
11.13.1 Quidel Company Detail
11.13.2 Quidel Business Overview
11.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Introduction
11.13.4 Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.13.5 Quidel Recent Development
11.14 GenMark Diagnostics
11.14.1 GenMark Diagnostics Company Detail
11.14.2 GenMark Diagnostics Business Overview
11.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
11.14.4 GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.14.5 GenMark Diagnostics Recent Development
11.15 Hologic
11.15.1 Hologic Company Detail
11.15.2 Hologic Business Overview
11.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Introduction
11.15.4 Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.15.5 Hologic Recent Development
11.16 OraSure Technologies
11.16.1 OraSure Technologies Company Detail
11.16.2 OraSure Technologies Business Overview
11.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Introduction
11.16.4 OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.16.5 OraSure Technologies Recent Development
11.17 Qualigen
11.17.1 Qualigen Company Detail
11.17.2 Qualigen Business Overview
11.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Introduction
11.17.4 Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
11.17.5 Qualigen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Chlamydia testing
Table 3. Key Players of Syphilis testing
Table 4. Key Players of Gonorrhoea testing
Table 5. Key Players of Herpes simplex virus testing
Table 6. Key Players of Human papilloma virus testing
Table 7. Key Players of Human immunodeficiency virus testing
Table 8. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2018-2023)
Table 12. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2024-2033)
Table 14. Sexually Transmitted Disease (STD) Diagnosis Market Trends
Table 15. Sexually Transmitted Disease (STD) Diagnosis Market Drivers
Table 16. Sexually Transmitted Disease (STD) Diagnosis Market Challenges
Table 17. Sexually Transmitted Disease (STD) Diagnosis Market Restraints
Table 18. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players (2018-2023)
Table 20. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2022)
Table 21. Ranking of Global Top Sexually Transmitted Disease (STD) Diagnosis Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Sexually Transmitted Disease (STD) Diagnosis Product Solution and Service
Table 25. Date of Enter into Sexually Transmitted Disease (STD) Diagnosis Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2018-2023)
Table 29. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2024-2033)
Table 31. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2018-2023)
Table 33. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2024-2033)
Table 35. North America Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2024-2033) & (US$ Million)
Table 50. Abbott Company Detail
Table 51. Abbott Business Overview
Table 52. Abbott Sexually Transmitted Disease (STD) Diagnosis Product
Table 53. Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Roche Company Detail
Table 56. Roche Business Overview
Table 57. Roche Sexually Transmitted Disease (STD) Diagnosis Product
Table 58. Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 59. Roche Recent Development
Table 60. Thermo Fisher Scientific Company Detail
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product
Table 63. Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 64. Thermo Fisher Scientific Recent Development
Table 65. Aposcience Company Detail
Table 66. Aposcience Business Overview
Table 67. Aposcience Sexually Transmitted Disease (STD) Diagnosis Product
Table 68. Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 69. Aposcience Recent Development
Table 70. BCR Diagnostics Company Detail
Table 71. BCR Diagnostics Business Overview
Table 72. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product
Table 73. BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 74. BCR Diagnostics Recent Development
Table 75. BD Medical Company Detail
Table 76. BD Medical Business Overview
Table 77. BD Medical Sexually Transmitted Disease (STD) Diagnosis Product
Table 78. BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 79. BD Medical Recent Development
Table 80. Biocartis Company Detail
Table 81. Biocartis Business Overview
Table 82. Biocartis Sexually Transmitted Disease (STD) Diagnosis Product
Table 83. Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 84. Biocartis Recent Development
Table 85. BioMerieux Company Detail
Table 86. BioMerieux Business Overview
Table 87. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Product
Table 88. BioMerieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 89. BioMerieux Recent Development
Table 90. Bio-Rad Company Detail
Table 91. Bio-Rad Business Overview
Table 92. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product
Table 93. Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 94. Bio-Rad Recent Development
Table 95. Cepheid Company Detail
Table 96. Cepheid Business Overview
Table 97. Cepheid Sexually Transmitted Disease (STD) Diagnosis Product
Table 98. Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 99. Cepheid Recent Development
Table 100. Danaher Company Detail
Table 101. Danaher Business Overview
Table 102. Danaher Sexually Transmitted Disease (STD) Diagnosis Product
Table 103. Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 104. Danaher Recent Development
Table 105. DiaSorin Company Detail
Table 106. DiaSorin Business Overview
Table 107. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product
Table 108. DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 109. DiaSorin Recent Development
Table 110. Quidel Company Detail
Table 111. Quidel Business Overview
Table 112. Quidel Sexually Transmitted Disease (STD) Diagnosis Product
Table 113. Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 114. Quidel Recent Development
Table 115. GenMark Diagnostics Company Detail
Table 116. GenMark Diagnostics Business Overview
Table 117. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product
Table 118. GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 119. GenMark Diagnostics Recent Development
Table 120. Hologic Company Detail
Table 121. Hologic Business Overview
Table 122. Hologic Sexually Transmitted Disease (STD) Diagnosis Product
Table 123. Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 124. Hologic Recent Development
Table 125. OraSure Technologies Company Detail
Table 126. OraSure Technologies Business Overview
Table 127. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product
Table 128. OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 129. OraSure Technologies Recent Development
Table 130. Qualigen Company Detail
Table 131. Qualigen Business Overview
Table 132. Qualigen Sexually Transmitted Disease (STD) Diagnosis Product
Table 133. Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023) & (US$ Million)
Table 134. Qualigen Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Type: 2022 VS 2033
Figure 3. Chlamydia testing Features
Figure 4. Syphilis testing Features
Figure 5. Gonorrhoea testing Features
Figure 6. Herpes simplex virus testing Features
Figure 7. Human papilloma virus testing Features
Figure 8. Human immunodeficiency virus testing Features
Figure 9. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Application: 2022 VS 2033
Figure 11. Government organizations Case Studies
Figure 12. Hospitals Case Studies
Figure 13. Diagnostic clinics Case Studies
Figure 14. Sexually Transmitted Disease (STD) Diagnosis Report Years Considered
Figure 15. Global Sexually Transmitted Disease (STD) Diagnosis Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Sexually Transmitted Disease (STD) Diagnosis Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region: 2022 VS 2033
Figure 18. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players in 2022
Figure 19. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2022
Figure 21. North America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2018-2033)
Figure 23. United States Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2018-2033)
Figure 27. Germany Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2018-2033)
Figure 35. China Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2018-2033)
Figure 43. Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2018-2033)
Figure 47. Turkey Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 50. Roche Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 52. Aposcience Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 53. BCR Diagnostics Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 54. BD Medical Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 55. Biocartis Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 56. BioMerieux Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 57. Bio-Rad Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 58. Cepheid Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 59. Danaher Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 60. DiaSorin Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 61. Quidel Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 62. GenMark Diagnostics Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 63. Hologic Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 64. OraSure Technologies Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 65. Qualigen Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed